A Phase II Clinical Trial of Pembrolizumab Efficacy and Safety in Advanced Renal Medullary Carcinoma.
Chijioke NzePavlos MsaouelMohamed H DerbalaBettzy StephenAbdulrahman AbonofalFunda Meric-BernstamNizar M TannirAung NaingPublished in: Cancers (2023)
This prospective evaluation showed no evidence of clinical activity for pembrolizumab in patients with RMC, irrespective of PD-L1 or TIL levels.